retatrutide triple agonist glp-1 gip glucagon phase 2 results From Obesity to Metabolic Health: Why Is a Game-Changer Mounjaro: Retatrutide and Diabetes -

The synergistic pharmacological mechanisms of GLP-1 RAs combined with metformin may modulate the expression of reproductive function-related hormonal indicators, thereby ameliorating endocrine disturbances and restoring normal menstrual cycles

Further prospective studies, particularly on long-term users and high-risk surgical populations, may refine recommendations on fasting duration, imaging use, and anaesthetic modifications

(ii) What is the fertility time window (1 year/preparing for IVF

(R-KS) sent a bipartisan letter to the FDA flagging Hims & Hers' ad and accusing the company of misleading patients "by omitting any safety or side effect information when promoting a specific type of weight loss medication." Under federal law and regulations, FDA requires that prescription drug advertisements be truthful, not misleading, and balancedfailure to do so risks FDA enforcement action, including civil monetary penalties, Durbin and Marshall said in the letter

Advancements in drug formulations, synergistic combinations with other antidiabetic medications, and improved safety profiles are poised to drive market expansion during the forecast period